Literature DB >> 12850263

The C-terminal domain of the Plasmodium falciparum acyl-CoA synthetases PfACS1 and PfACS3 functions as ligand for ankyrin.

Maria- del-Mar Téllez1, Fuencisla Matesanz, Antonio Alcina.   

Abstract

Infection of erythrocytes by the malaria parasite Plasmodium falciparum results in the export of several parasite proteins into the erythrocyte cytoplasm establishing novel interactions between host and parasite proteins, particularly at the membrane skeleton that modifies both the structural and functional properties of the red cell. We present evidences that two members of the P. falciparum acyl-CoA synthetase (PfACS) family, responsible for the activation of long-chain fatty acids by thio-esterification with CoA, are transported in vesicle-like structures toward the host erythrocyte cytoplasm where they interact with the cytoskeletal protein ankyrin. Carboxyl-terminal domain (CTD) overlay studies indicated that PfACS1 and PfACS3 bind to the 78-kDa fragment of ankyrin corresponding with its spectrin-binding domain. Co-immunoprecipitation of ankyrin and PfACS1/3 indicates that at least a fraction of these proteins are physically associated in the infected erythrocytes and provide evidence for a novel specific interaction which suggest that such a binding may bring these enzymes closer to the host erythrocyte membrane where exogenous fatty acids are available.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850263     DOI: 10.1016/s0166-6851(03)00123-3

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  9 in total

1.  Protein targeting to the parasitophorous vacuole membrane of Plasmodium falciparum.

Authors:  Saliha Eksi; Kim C Williamson
Journal:  Eukaryot Cell       Date:  2011-04-15

2.  An erythrocyte cytoskeleton-binding motif in exported Plasmodium falciparum proteins.

Authors:  Geoffrey K Kilili; Douglas J LaCount
Journal:  Eukaryot Cell       Date:  2011-09-09

Review 3.  Malaria parasite proteins that remodel the host erythrocyte.

Authors:  Alexander G Maier; Brian M Cooke; Alan F Cowman; Leann Tilley
Journal:  Nat Rev Microbiol       Date:  2009-05       Impact factor: 60.633

4.  The Plasmodium falciparum exported protein PF3D7_0402000 binds to erythrocyte ankyrin and band 4.1.

Authors:  Bikash Shakya; Wesley D Penn; Ernesto S Nakayasu; Douglas J LaCount
Journal:  Mol Biochem Parasitol       Date:  2017-06-13       Impact factor: 1.845

5.  Revealing parasite influence in metabolic pathways in Apicomplexa infected patients.

Authors:  Tao Xu; Jie Ping; Yao Yu; Fudong Yu; Yongtao Yu; Pei Hao; Xuan Li
Journal:  BMC Bioinformatics       Date:  2010-12-14       Impact factor: 3.169

6.  Transcriptional variation in the malaria parasite Plasmodium falciparum.

Authors:  Núria Rovira-Graells; Archna P Gupta; Evarist Planet; Valerie M Crowley; Sachel Mok; Lluís Ribas de Pouplana; Peter R Preiser; Zbynek Bozdech; Alfred Cortés
Journal:  Genome Res       Date:  2012-03-13       Impact factor: 9.043

7.  Dynamic RNA profiling in Plasmodium falciparum synchronized blood stages exposed to lethal doses of artesunate.

Authors:  Onguma Natalang; Emmanuel Bischoff; Guillaume Deplaine; Caroline Proux; Marie-Agnès Dillies; Odile Sismeiro; Ghislaine Guigon; Serge Bonnefoy; Jintana Patarapotikul; Odile Mercereau-Puijalon; Jean-Yves Coppée; Peter H David
Journal:  BMC Genomics       Date:  2008-08-18       Impact factor: 3.969

8.  A splice variant in the ACSL5 gene relates migraine with fatty acid activation in mitochondria.

Authors:  Fuencisla Matesanz; María Fedetz; Cristina Barrionuevo; Mohamad Karaky; Antonio Catalá-Rabasa; Victor Potenciano; Raquel Bello-Morales; Jose-Antonio López-Guerrero; Antonio Alcina
Journal:  Eur J Hum Genet       Date:  2016-05-18       Impact factor: 4.246

9.  Genetic conflicts with Plasmodium parasites and functional constraints shape the evolution of erythrocyte cytoskeletal proteins.

Authors:  Manuela Sironi; Diego Forni; Mario Clerici; Rachele Cagliani
Journal:  Sci Rep       Date:  2018-10-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.